Cancer Immunotherapy Hampered by T Cell Inhibitory Checkpoint VISTA Protein
A Cleveland Clinic-led team of scientists and physicians has discovered that the immune checkpoint protein VISTA can directly turn off tumor-fighting T cells during immunotherapy and resist treatment. The team’s preclinical study, including work using …